0001209191-22-034538.txt : 20220606
0001209191-22-034538.hdr.sgml : 20220606
20220606164142
ACCESSION NUMBER: 0001209191-22-034538
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220603
FILED AS OF DATE: 20220606
DATE AS OF CHANGE: 20220606
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Markels John
CENTRAL INDEX KEY: 0001803424
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30171
FILM NUMBER: 22998564
MAIL ADDRESS:
STREET 1: C/O SANGAMO THERAPEUTICS, INC.
STREET 2: POINT RICHMOND TECH CTR, 501 CANAL BLVD.
CITY: RICHMOND
STATE: CA
ZIP: 94804
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SANGAMO THERAPEUTICS, INC
CENTRAL INDEX KEY: 0001001233
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 680359556
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7000 MARINA BLVD
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 5109706000
MAIL ADDRESS:
STREET 1: 7000 MARINA BLVD
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER COMPANY:
FORMER CONFORMED NAME: SANGAMO BIOSCIENCES INC
DATE OF NAME CHANGE: 20000208
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-03
0
0001001233
SANGAMO THERAPEUTICS, INC
SGMO
0001803424
Markels John
C/O SANGAMO THERAPEUTICS, INC.
7000 MARINA BLVD.
BRISBANE
CA
94005
1
0
0
0
Common Stock
2022-06-03
4
P
0
6784
3.6894
A
32484
D
Includes (a) 1,667 shares subject to the Reporting Person's February 11, 2020 restricted stock unit ("RSU") grant that will vest in one final annual installment on February 11, 2023 and (b) 12,500 shares subject to the Reporting Person's February 25, 2022 RSU grant that will fully vest in one installment on February 25, 2023. The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the "2018 EIP")) through each such date and subject to acceleration as provided in the 2018 EIP.
John Markels, by /s/ Ron A. Metzger, Attorney-in-Fact
2022-06-06